This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q66034207
rdf:type
wikibase:Item
schema:description
klinisch onderzoek ensaio clínico clinical trial clinical trial clinical trial clinical trial essai clinique ensayu clínicu assaig clínic клінічне випробування ensayo clínico
rdfs:label
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
skos:prefLabel
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
schema:name
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
p:P1476
wds:Q66034207-01C8002C-31BB-45B2-BC5D-3AF265E66190
wdt:P1476
A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors
p:P582
wds:Q66034207-0DE19C01-F9A0-4B9C-ACE2-B02EB60611EB
wdt:P582
2003-11-01T00:00:00Z
p:P31
wds:Q66034207-80A4265E-7FF9-4188-9701-B6902A58841D
wdt:P31
wd:Q30612
p:P580
wds:Q66034207-C0B841FD-CA2A-49CA-A035-376D0B1D4D16
wdt:P580
1998-01-01T00:00:00Z
p:P17
wds:Q66034207-ABCA627A-9019-4B50-851C-D90183F4D80E
wdt:P17
wd:Q30
p:P921
wds:Q66034207-D0DB1BDE-65DC-464A-922D-2997E4B1B66E wds:Q66034207-8FCFCF33-0C09-448B-B501-92CD62C9B1A0
wdt:P921
wd:Q19000759 wd:Q18557324
p:P2899
wds:Q66034207-8FB9A974-72B3-4C98-9C53-C2E4AB0D43B3
wdt:P2899
18
p:P1050
wds:Q66034207-BF4E7117-4FFD-4ABC-9289-C2A0A839E026 wds:Q66034207-FD87DE95-ECC3-4750-9B16-C50B7D4E846E
p:P859
wds:Q66034207-53E6A3EE-091F-46B5-84C8-30777AED90C7
wdt:P1050
wd:Q180614 wd:Q208414
wdt:P859
wd:Q507154
p:P1132
wds:Q66034207-D0DD480E-DCBD-490D-BB69-39359F3D4BA8
wdt:P1132
60
p:P8363
wds:Q66034207-A4EBEC72-A4C4-4387-BA0D-1322DFCBA20D
wdt:P8363
wd:Q78089383
p:P3098
wds:Q66034207-813E5300-FDC0-484B-A9E4-7558CE2122D1
wdt:P3098
NCT00006368
p:P6099
wds:Q66034207-80CD8186-1593-4C1F-95C2-ED9F129E9A8B
wdt:P6099
wd:Q5452194